Europe PMC
open access
Radiobiological and immunomodulatory mechanisms of CAIX-targeted α therapy combined with immune checkpoint inhibition in hypoxic tumors
Abstract Purpose Tumor hypoxia is associated with tumor aggressiveness and therapy resistance. Targeted α therapy (TAT) offers a promising approach to eliminate hypoxic tumor cells, as α-particles induce complex DNA damage independent of oxygen availability. We previously demons
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma#1259536
- Editorial: Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms#1298941
- The blockade of immune checkpoints in cancer immunotherapy#6784
- Immunotherapy Based on Tumor Associated Antigen-specific Immune Effector Cells#460083
- Observational Prospective Study of Immune Checkpoint Inhibitors for Solid Neoplasms#1045896
Record · ID 1414844
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive